Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026)

Compugen's (CGEN) quarterly Non-Current Deffered Revenue came in at $22.1 million in Q1 2026, down 30.31% year-on-year from $31.8 million in Q1 2025, and down 11.24% quarter-over-quarter from $24.9 million in Q4 2025.

Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

Compugen has disclosed Non-Current Deffered Revenue across 5 years of filings, most recently posting $22.1 million for Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $22.1 million, down 30.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.1 million (down 30.31% YoY), and the FY2025 annual result was $24.9 million, down 26.74% from the prior year.
  • Non-Current Deffered Revenue came in at $22.1 million for Q1 2026 at Compugen, down from $24.9 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $34.0 million in Q4 2024 to a low of $21.0 million in Q2 2024.
  • The 4-year median for Non-Current Deffered Revenue is $26.5 million (2023), against an average of $26.9 million.
  • Across the five-year window, Non-Current Deffered Revenue jumped 40.73% in 2025 and slumped 30.31% in 2026, its largest moves.
  • Compugen's Non-Current Deffered Revenue stood at $25.4 million in 2023, then soared by 34.08% to $34.0 million in 2024, then fell by 26.74% to $24.9 million in 2025, then retreated by 11.24% to $22.1 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $22.1 million (Q1 2026), $24.9 million (Q4 2025), and $27.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 22.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.14 Mn
Dec 31, 2025 24.94 Mn
Sep 30, 2025 27.57 Mn
Jun 30, 2025 29.59 Mn
Mar 31, 2025 31.77 Mn
Dec 31, 2024 34.05 Mn
Sep 30, 2024 29.24 Mn
Jun 30, 2024 21.03 Mn
Mar 31, 2024 23.23 Mn
Dec 31, 2023 25.39 Mn
Dec 31, 2013 1.45 Mn